Anbio Biotechnology [NNNN] vs AptarGroup [ATR] Detailed Stock Comparison

Anbio Biotechnology

NASDAQ
Loading...

AptarGroup

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Anbio Biotechnology wins in 4 metrics, AptarGroup wins in 11 metrics, with 0 ties. AptarGroup appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAnbio BiotechnologyAptarGroupBetter
P/E Ratio (TTM)912.1023.68AptarGroup
Price-to-Book Ratio112.053.34AptarGroup
Debt-to-Equity Ratio0.0043.12Anbio Biotechnology
PEG RatioN/A0.98N/A
EV/EBITDA849.9212.51AptarGroup
Profit Margin (TTM)28.99%10.84%Anbio Biotechnology
Operating Margin (TTM)-68.64%15.17%AptarGroup
EBITDA Margin (TTM)N/A15.17%N/A
Return on Equity14.83%15.26%AptarGroup
Return on Assets (TTM)7.18%7.10%Anbio Biotechnology
Free Cash Flow (TTM)$2.08M$349.22MAptarGroup
Dividend YieldN/A0.90%N/A
1-Year Return694.11%-11.20%Anbio Biotechnology
Price-to-Sales Ratio (TTM)244.552.50AptarGroup
Enterprise Value$2.00B$10.00BAptarGroup
EV/Revenue Ratio244.262.77AptarGroup
Gross Profit Margin (TTM)N/A37.99%N/A
Revenue per Share (TTM)$0$54AptarGroup
Earnings per Share (Diluted)$0.05$5.79AptarGroup
Beta (Stock Volatility)N/A0.57N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Anbio Biotechnology vs AptarGroup Stock Performance Analysis

Loading Price Chart...

Anbio Biotechnology
AptarGroup
Anbio Biotechnology Stock Overview | AptarGroup Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Anbio Biotechnology-4.24%0.37%-10.26%444.18%637.84%694.11%
AptarGroup-1.36%-2.45%-3.05%-12.39%-7.40%-12.28%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Anbio Biotechnology694.11%694.11%694.11%694.11%694.11%694.11%
AptarGroup-11.20%31.74%17.54%101.37%198.70%456.46%

News Based Sentiment: Anbio Biotechnology vs AptarGroup

Anbio Biotechnology

News based Sentiment: MIXED

Anbio Biotechnology experienced significant share price gains and maintains positive cash flow, but is grappling with declining revenue and a lack of analyst coverage. This creates a mixed investment picture with both opportunities and risks, making it a noteworthy story for investors this month.

View Anbio Biotechnology News Sentiment Analysis

AptarGroup

News based Sentiment: MIXED

AptarGroup delivered a strong second quarter and continued its long history of dividend increases, attracting positive analyst coverage. However, the simultaneous insider selling activity introduces a note of caution, creating a mixed investment narrative for the month.

View AptarGroup News Sentiment Analysis

Performance & Financial Health Analysis: Anbio Biotechnology vs AptarGroup

MetricNNNNATR
Market Information
Market Cap i$2.10B$8.91B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i49,830464,277
90 Day Avg. Volume i86,237522,029
Last Close$45.82$135.23
52 Week Range$5.18 - $55.65$130.85 - $178.03
% from 52W High-17.66%-24.04%
All-Time High$55.65 (Jul 15, 2025)$178.03 (Nov 11, 2024)
% from All-Time High-17.66%-24.04%
Growth Metrics
Quarterly Revenue Growth-0.36%0.06%
Quarterly Earnings GrowthN/A0.24%
Financial Health
Profit Margin (TTM) i0.29%0.11%
Operating Margin (TTM) i-0.69%0.15%
Return on Equity (TTM) i0.15%0.15%
Debt to Equity (MRQ) i0.0043.12
Cash & Liquidity
Book Value per Share (MRQ)$0.41$41.04
Cash per Share (MRQ)$0.27$2.58
Operating Cash Flow (TTM) i$2.08M$616.20M
Levered Free Cash Flow (TTM) i$1.27M$291.79M
Dividends
Last 12-Month Dividend Yield iN/A0.90%
Last 12-Month Dividend iN/A$1.35

Valuation & Enterprise Metrics Analysis: Anbio Biotechnology vs AptarGroup

MetricNNNNATR
Price Ratios
P/E Ratio (TTM) i912.1023.68
Forward P/E iN/A23.12
PEG Ratio iN/A0.98
Price to Sales (TTM) i244.552.50
Price to Book (MRQ) i112.053.34
Market Capitalization
Market Capitalization i$2.10B$8.91B
Enterprise Value i$2.00B$10.00B
Enterprise Value Metrics
Enterprise to Revenue i244.262.77
Enterprise to EBITDA i849.9212.51
Risk & Other Metrics
Beta iN/A0.57
Book Value per Share (MRQ) i$0.41$41.04

Financial Statements Comparison: Anbio Biotechnology vs AptarGroup

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NNNNATR
Revenue/Sales iN/A$887.31M
Cost of Goods Sold iN/A$550.89M
Gross Profit iN/A$336.41M
Research & Development iN/AN/A
Operating Income (EBIT) iN/A$115.49M
EBITDA iN/A$186.15M
Pre-Tax Income iN/A$106.02M
Income Tax iN/A$27.35M
Net Income (Profit) iN/A$78.66M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NNNNATR
Cash & Equivalents i$11.76M$125.84M
Total Current Assets i$18.53M$1.51B
Total Current Liabilities i$1.73M$1.21B
Long-Term Debt iN/A$612.02M
Total Shareholders Equity i$17.19M$2.55B
Retained Earnings i$17.17M$2.42B
Property, Plant & Equipment iN/A$66.57M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NNNNATR
Operating Cash Flow iN/A$100.50M
Capital Expenditures iN/A$79,000
Free Cash Flow iN/A$23.41M
Debt Repayment iN/A$-4.55M
Common Stock Repurchase iN/A$-80.00M

Short Interest & Institutional Ownership Analysis

MetricNNNNATR
Shares Short i154,246944,016
Short Ratio i1.281.79
Short % of Float i0.00%0.02%
Average Daily Volume (10 Day) i49,830464,277
Average Daily Volume (90 Day) i86,237522,029
Shares Outstanding i43.89M66.50M
Float Shares i39.69M65.33M
% Held by Insiders i0.05%0.01%
% Held by Institutions i0.05%0.96%

Dividend Analysis & Yield Comparison: Anbio Biotechnology vs AptarGroup

MetricNNNNATR
Last 12-Month Dividend iN/A$1.35
Last 12-Month Dividend Yield iN/A0.90%
3-Year Avg Annual Dividend iN/A$1.50
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A$4.51
Ex-Dividend DateN/AFeb 05, 2025